MedTrace Logo

Florida Cerebrovascular Disease Biorepository and Genomics Center

NCT05491980 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2026-05-13

No results posted yet for this study

Summary

The purpose of this study is to create a state-wide biorepository and resource center for cerebrovascular diseases in Florida, which will include collecting medical history information and blood from subjects affected by cerebrovascular disease. The information and blood samples collected may be used in future research for the study of cerebrovascular disease and to learn about, prevent or treat other health problems.

Conditions

  • Cerebrovascular Disease
  • Ischemic Stroke
  • Transient Ischemic Attack
  • Intracerebral Hemorrhage
  • Aneurysmal Subarachnoid Hemorrhage
  • Vascular Dementia
  • Anoxic Brain Injury
  • Unruptured Intracranial Aneurysm
  • Carotid Artery Stenosis Symptomatic
  • Asymptomatic Carotid Artery Stenosis
  • Non-Aneurysmal Perimesencephalic Subarachnoid Haemorrhage
  • Cerebral Venous Thrombosis
  • Moyamoya Disease
  • Fibromuscular Dysplasia
  • Subarachnoid Hemorrhage
  • Leukoaraiosis
  • Arteriovenous Fistula
  • Reversible Cerebral Vasoconstriction Syndrome
  • CADASIL

Sponsors & Collaborators

Principal Investigators

  • James Meschia, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-02
Primary Completion
2026-06-30
Completion
2026-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05491980 on ClinicalTrials.gov